Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care.

Hirst JA, Montes MDV, Taylor CJ, Ordóñez-Mena JM, Ogburn E, Sharma V, Shine B, James T, Hobbs FR.

Br J Gen Pract. 2018 Jul 2. pii: bjgp18X697937. doi: 10.3399/bjgp18X697937. [Epub ahead of print]

PMID:
29970394
2.

Systematic Review and Metaanalysis Comparing the Bias and Accuracy of the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration Equations in Community-Based Populations.

McFadden EC, Hirst JA, Verbakel JY, McLellan JH, Hobbs FDR, Stevens RJ, O'Callaghan CA, Lasserson DS.

Clin Chem. 2018 Mar;64(3):475-485. doi: 10.1373/clinchem.2017.276683. Epub 2017 Oct 18. Review.

PMID:
29046330
3.

How can point-of-care HbA1c testing be integrated into UK primary care consultations? - A feasibility study.

Hirst JA, Stevens RJ, Smith I, James T, Gudgin BC, Farmer AJ.

Diabetes Res Clin Pract. 2017 Aug;130:113-120. doi: 10.1016/j.diabres.2017.05.014. Epub 2017 May 18.

4.

Short- and medium-term effects of light to moderate alcohol intake on glycaemic control in diabetes mellitus: a systematic review and meta-analysis of randomized trials.

Hirst JA, Aronson JK, Feakins BG, Ma C, Farmer AJ, Stevens RJ.

Diabet Med. 2017 May;34(5):604-611. doi: 10.1111/dme.13259. Epub 2016 Oct 13. Review.

PMID:
27588354
5.

Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.

Hirst JA, McLellan JH, Price CP, English E, Feakins BG, Stevens RJ, Farmer AJ.

Clin Chem Lab Med. 2017 Feb 1;55(2):167-180. doi: 10.1515/cclm-2016-0303. Review.

6.

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD.

PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016. Review.

7.

Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.

Hirst JA, Farmer AJ, Feakins BG, Aronson JK, Stevens RJ.

Br J Clin Pharmacol. 2015 May;79(5):733-43. doi: 10.1111/bcp.12543.

8.

The need for randomization in animal trials: an overview of systematic reviews.

Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C.

PLoS One. 2014 Jun 6;9(6):e98856. doi: 10.1371/journal.pone.0098856. eCollection 2014. Review.

9.

Diagnostic accuracy of point-of-care tests for detecting albuminuria: a systematic review and meta-analysis.

McTaggart MP, Newall RG, Hirst JA, Bankhead CR, Lamb EJ, Roberts NW, Price CP.

Ann Intern Med. 2014 Apr 15;160(8):550-7. doi: 10.7326/M13-2331. Review.

PMID:
24733196
10.

Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.

Hirst JA, Stevens RJ, Farmer AJ.

PLoS One. 2014 Mar 25;9(3):e92458. doi: 10.1371/journal.pone.0092458. eCollection 2014.

11.

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis.

Hirst JA, Farmer AJ, Dyar A, Lung TW, Stevens RJ.

Diabetologia. 2013 May;56(5):973-84. doi: 10.1007/s00125-013-2856-6. Epub 2013 Mar 15. Review.

12.

Bailout antegrade coronary reentry with the stingray™ balloon and guidewire in the setting of an acute myocardial infarction and cardiogenic shock.

Azemi T, Fram DB, Hirst JA.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E211-4. doi: 10.1002/ccd.24826. Epub 2013 Mar 16.

PMID:
23404924
13.

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Stevens RJ, Ali R, Bankhead CR, Bethel MA, Cairns BJ, Camisasca RP, Crowe FL, Farmer AJ, Harrison S, Hirst JA, Home P, Kahn SE, McLellan JH, Perera R, Plüddemann A, Ramachandran A, Roberts NW, Rose PW, Schweizer A, Viberti G, Holman RR.

Diabetologia. 2012 Oct;55(10):2593-2603. doi: 10.1007/s00125-012-2653-7. Epub 2012 Aug 10. Review. Erratum in: Diabetologia. 2012 Dec;55(12):3399-400.

PMID:
22875195
14.

Quantifying the effect of metformin treatment and dose on glycemic control.

Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ.

Diabetes Care. 2012 Feb;35(2):446-54. doi: 10.2337/dc11-1465.

15.

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.

Hirst JA, Taylor KS, Stevens RJ, Blacklock CL, Roberts NW, Pugh CW, Farmer AJ.

Kidney Int. 2012 Apr;81(7):674-83. doi: 10.1038/ki.2011.413. Epub 2011 Dec 21.

16.

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.

Blacklock CL, Hirst JA, Taylor KS, Stevens RJ, Roberts NW, Farmer AJ.

Diabet Med. 2011 Oct;28(10):1182-7. doi: 10.1111/j.1464-5491.2011.03341.x.

PMID:
21627686
17.

Use of prehospital electrocardiograms for the treatment of patients with ST-segment elevation myocardial infarction.

Dada MR, Hirst JA, Kiernan FJ, Smally AJ, Lundbye JB, Thompson PD, McKay RG.

Conn Med. 2009 Feb;73(2):69-72.

PMID:
19263736
18.

Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

McKay RG, Dada MR, Mather JF, Mennet RR, Murphy DJ, Maloney KW, Hirst JA, Kiernan FJ.

Am J Cardiol. 2009 Feb 1;103(3):316-21. doi: 10.1016/j.amjcard.2008.09.078. Epub 2008 Nov 17.

PMID:
19166682
19.

Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase.

Hoshino A, Hirst JA, Fujii H.

J Biol Chem. 2007 Jun 15;282(24):17706-11. Epub 2007 Apr 19.

20.

Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women.

Elkoustaf RA, Mamkin I, Mather JF, Murphy D, Hirst JA, Kiernan FJ, McKay RG.

Am J Cardiol. 2006 Jul 15;98(2):182-6. Epub 2006 May 19.

PMID:
16828589
21.

Cell type-specific expression profiling in plants via cell sorting of protoplasts from fluorescent reporter lines.

Birnbaum K, Jung JW, Wang JY, Lambert GM, Hirst JA, Galbraith DW, Benfey PN.

Nat Methods. 2005 Aug;2(8):615-9. No abstract available.

PMID:
16170893
22.

HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent.

Jin YJ, Cai CY, Zhang X, Zhang HT, Hirst JA, Burakoff SJ.

J Immunol. 2005 Sep 1;175(5):3157-64. Erratum in: J Immunol. 2006 Feb 15;176(4):2669.

23.

Inducible translocation trap: a system for detecting inducible nuclear translocation.

Hoshino A, Matsumura S, Kondo K, Hirst JA, Fujii H.

Mol Cell. 2004 Jul 2;15(1):153-9.

24.

Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia: an angioplasty model.

Fram DB, Azar RR, Ahlberg AW, Gillam LD, Mitchel JF, Kiernan FJ, Hirst JA, Mather JF, Ficaro E, Cyr G, Waters D, Heller GV.

J Am Coll Cardiol. 2003 Feb 5;41(3):452-9.

25.

Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction.

Azar RR, Waters DD, McKay RG, Giri S, Hirst JA, Mitchell JF, Fram DB, Kiernan FJ.

Am J Cardiol. 2000 Mar 15;85(6):675-9.

PMID:
12000039
26.

Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock.

Giri S, Mitchel J, Azar RR, Kiernan FJ, Fram DB, McKay RG, Mennett R, Clive J, Hirst JA.

Am J Cardiol. 2002 Jan 15;89(2):126-31.

PMID:
11792329
27.

Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction.

Giri S, Mitchel JF, Hirst JA, McKay RG, Azar RR, Mennett R, Waters DD, Kiernan FJ.

Am J Cardiol. 2000 Aug 1;86(3):269-74.

PMID:
10922431
28.

Clinical and angiographic characteristics of exertion-related acute myocardial infarction.

Giri S, Thompson PD, Kiernan FJ, Clive J, Fram DB, Mitchel JF, Hirst JA, McKay RG, Waters DD.

JAMA. 1999 Nov 10;282(18):1731-6. Erratum in: JAMA 1999 Dec 8;282(22):2124.

PMID:
10568645
29.

Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes.

Azar RR, McKay RG, Thompson PD, Hirst JA, Mitchell JF, Fram DB, Waters DD, Kiernan FJ.

J Am Coll Cardiol. 1998 Dec;32(7):1996-2002.

30.

Site-specific intracoronary thrombolysis with urokinase-coated hydrogel balloons: acute and follow-up studies in 95 patients.

Glazier JJ, Hirst JA, Kiernan FJ, Fram DB, Eldin AM, Primiano CA, Mitchel JF, McKay RG.

Cathet Cardiovasc Diagn. 1997 Jul;41(3):246-53.

PMID:
9213022
31.

Coronary stent placement as a bridge to coronary artery bypass surgery in an unstable, anemic Jehovah's Witness patient: a case report and review of bloodless surgery techniques.

Dougherty JE, Gallagher RC, Hirst JA, Rinaldi MJ, Biskup JM, Chamberlain RD, Waters D.

Conn Med. 1997 Apr;61(4):195-9. Review.

PMID:
9149480
32.
33.

Maintenance of coronary guidewire position during guide catheter exchange.

Azrin MA, Fram DB, Hirst JA, Mitchel JF, Mckay RG.

Cathet Cardiovasc Diagn. 1996 Apr;37(4):453-4.

PMID:
8721704
34.

Primary angioplasty using a urokinase-coated hydrogel balloon in acute myocardial infarction during pregnancy.

Glazier JJ, Eldin AM, Hirst JA, Dougherty JE, Mitchel JF, Waters DD, McKay RG.

Cathet Cardiovasc Diagn. 1995 Nov;36(3):216-9.

PMID:
8542627
35.

Intracardiac ultrasound imaging during transseptal catheterization.

Mitchel JF, Gillam LD, Sanzobrino BW, Hirst JA, McKay RG.

Chest. 1995 Jul;108(1):104-8.

PMID:
7606942
36.

Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies.

Mitchel JF, Fram DB, Palme DF 2nd, Foster R, Hirst JA, Azrin MA, Bow LM, Eldin AM, Waters DD, McKay RG.

Circulation. 1995 Feb 1;91(3):785-93.

37.

Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter.

McKay RG, Fram DB, Hirst JA, Kiernan FJ, Primiano CA, Rinaldi MJ, Azrin MA, Mitchel JF, Waters DD.

Cathet Cardiovasc Diagn. 1994 Oct;33(2):181-8.

PMID:
7834736
38.

Traumatic intramyocardial dissection secondary to significant blunt chest trauma: a case report.

Dougherty JE, Gabram SG, Glickstein MF, Hirst JA, Low HB.

J Trauma. 1993 Feb;34(2):300-2.

PMID:
8459476
39.

Intracardiac echocardiography in humans using a small-sized (6F), low frequency (12.5 MHz) ultrasound catheter. Methods, imaging planes and clinical experience.

Schwartz SL, Gillam LD, Weintraub AR, Sanzobrino BW, Hirst JA, Hsu TL, Fisher JP, Marx G, Fulton D, McKay RG, et al.

J Am Coll Cardiol. 1993 Jan;21(1):189-98.

40.

Separation of self-renewing hematopoietic progenitors on the basis of CD45 (T-200) antigen expression.

Basch RS, Oh YD, Saha CS, Fredrickson GG, Hirst JA.

Exp Hematol. 1992 Jan;20(1):11-6.

PMID:
1533593
41.
42.

Conditional requirement for accessory cells in the response of T cells to Con A.

Hoffmann MK, Chun M, Hirst JA.

Lymphokine Res. 1986 Winter;5(1):1-9.

PMID:
3484796
43.

The T-cell receptor recognizes nominal and self antigen independently. A theoretical alternative to the modified self concept.

Hoffmann MK, Chun M, Hirst JA, Hämmerling U.

Curr Top Microbiol Immunol. 1986;126:231-8. No abstract available.

PMID:
3087706
44.

Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphate.

Chun M, Krim M, Granelli-Piperno A, Hirst JA, Hoffmann MK.

Scand J Immunol. 1985 Oct;22(4):375-81.

PMID:
2416040
45.

IL 1 requirement for B cell activation revealed by use of adult serum.

Hoffmann MK, Mizel SB, Hirst JA.

J Immunol. 1984 Nov;133(5):2566-8.

PMID:
6384369
46.

Serum progesterone and fetal morphology following ovariectomy and adrenalectomy in the pregnant rat.

Butterstein GM, Hirst JA.

Biol Reprod. 1977 Jun;16(5):654-60. No abstract available.

PMID:
558810
47.

A new differentiation antigen defining a subpopulation of mouse T cells.

Kisielow P, Shiku H, Hirst JA.

Nature. 1976 May 13;261(5556):137-9. No abstract available.

PMID:
5683
48.

Ly antigens: markers of T cell function on mouse spleen cells.

Hirst JA, Beverley PC, Kisielow P, Hoffmann MK, Oettgen HF.

J Immunol. 1975 Dec;115(6):1555-7.

PMID:
1102601
49.

Suppression and enhancement of the T cell-dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide.

Hoffmann MK, Weiss O, Koenig S, Hirst JA, Oettgen HF.

J Immunol. 1975 Feb;114(2 pt 2):738-41.

PMID:
1089715
50.

Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse.

Kisielow P, Hirst JA, Shiku H, Beverley PC, Hoffman MK, Boyse EA, Oettgen HF.

Nature. 1975 Jan 17;253(5488):219-20. No abstract available.

PMID:
234178

Supplemental Content

Loading ...
Support Center